Gemcitabine plus radiation therapy in the treatment of locally advanced non-small-cell lung cancer

Research output: Contribution to journalArticle

Abstract

For stage III non-small-cell lung cancer, there is a need for better systemic, as well as locoregional, control of the tumor. In an attempt to enhance this locoregional control, systemic chemotherapy has been given currently with radiation therapy. Gemcitabine, a novel deoxycytidine analogue, has been shown to be a potent radiosensitizer. This review focuses on the studies using gemcitabine concurrently with radiation therapy in the treatment of locally advanced non-small-cell lung cancer.

Original languageEnglish (US)
Pages (from-to)S33-S38
JournalClinical lung cancer
Volume2
Issue numberSUPPL. 1
DOIs
StatePublished - Jan 1 2000
Externally publishedYes

    Fingerprint

Keywords

  • Gemcitabine
  • Radiation therapy
  • Radiosensitizer

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this